SAS Output

18-JUN-2019 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob 1 Y 1 TGR-1202 + Obinutuzumab 150 7 5 4 1 1 0 01/23/2018 260 94
        2 Lenalidomide + Obinutuzumab   7 6 4 2 1 1      
        3 CHOP + Obinutuzumab   7 4 3 1 1 1      
        4 Bendamustine + Obinutuzumab   4 4 3 3 1 0      
            25 19 14 7 4 2      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   55 3 0 0 0 0 10/12/2016 164 66
            55 3 0 0 0 0      
 
    1 E Total Registrations   6 0 0 0 0 0 10/12/2016    
            6 0 0 0 0 0      
 
  EA4151-Lymph, AHCT +/-Ritux, MRD Neg 0 E Total Registrations   26 21 11 5 2 1 04/03/2018 137 61
            26 21 11 5 2 1      
 
    1 E Total Registrations   19 18 10 4 2 0 04/03/2018    
            19 18 10 4 2 0      
 
No E4412-HD, RR, Ipilimumab +Nivo +Brentuximab Vedotin 1 E Total Registrations   3 3 3 3 1 0 04/17/2019   1
            3 3 3 3 1 0